Cantitate/Preț
Produs

GPCR Signaling in Cancer: Advances in Cancer Research, cartea 145

Arun K. Shukla
en Limba Engleză Hardback – 21 feb 2020
GPCR Signaling in Cancer, Volume 145, the latest release in the Advances in Cancer Research series, highlights recent developments in the area of GPCRs and cancer biology. Chapters included in this volume cover several GPCRs and their downstream effectors as case examples to highlight their fundamental understanding and therapeutic potential. Specific chapters address the Role of GRKs and beta-arrestins in cancer, Atypical GPCRs in cancer, the Role of a chemokine receptor (CCR) 5 in cancer, Targeting G protein-coupled receptors for therapeutics in cancer, Emerging GPCR signaling pathways in cancer, and more.
G protein-coupled receptors (GPCRs) constitute a large family of cell surface receptors which are involved in nearly every cellular and physiological event. These receptors can recognize a broad array of ligands and they are targeted by nearly one third of the currently prescribed drugs including anti-cancer therapeutics.


  • Covers the latest concepts in GPCR signaling and their relevancy to cancer biology
  • Presents new indications for anti-cancer therapeutic programs
  • Includes sections on cross-talk and signaling networks of GPCRs and effectors in molecular oncology and therapeutics
Citește tot Restrânge

Din seria Advances in Cancer Research

Preț: 71917 lei

Preț vechi: 101832 lei
-29% Nou

Puncte Express: 1079

Preț estimativ în valută:
13768 15007$ 11577£

Carte tipărită la comandă

Livrare economică 11-25 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128202302
ISBN-10: 0128202300
Pagini: 164
Dimensiuni: 152 x 229 x 10 mm
Greutate: 0.4 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Cancer Research


Public țintă

Primary researchers and clinicians involved in molecular oncology research and cancer therapeutics

Cuprins

1. HERs Transregulation in Cancer Progression: From Discovery to 2020 and Beyond Rakesh Kumar 2. RTKs in Cancer Biology Paul Fisher 3. Advances in EGFR Biochemistry and Biology Yosef Yarden 4. Mouse Models of RTKs/HERs: Lessons and Implications to Biology and Therapy William Joseph Muller 5. MET Receptor in Oncology: From Biomarker to Therapeutic Target Ravi Salgia 6. RTKs in Pathobiology of Head & Neck Cancer Radhakrishna Pillai 7. HER2 or Nuclear HER/RTK in Cancer Mien-Chie Hung 8. FLT3 in Hematopietic Malignancies: From Pathobiology to Therapeutics Premkumar Reddy 9. Advances in IGF1R Biology and –directed Cancer Therapeutics Douglas Yee 10. Advances in Bcr-Abl in Cancer Therapy and Biology Nandini Verma 11. EphRs in Cancer Development and Progression Renata Pasqualini 12. RTK-directed Clinical Advances: Trials and Treatments Masakazu Toi